-Bloomberg
Morgan Stanley Maintains Underweight on Omnicom Group, Lowers Price Target to $70
Morgan Stanley maintains Omnicom Group (NYSE:OMC) with a Underweight and lowers the price target from $84 to $70.
Related Posts
Amyris Reports Completion Of Previously-Announced Joint Venture Deal With MF 92 VENTURES To Develop Molecules For Sustainable Production, Distribution Of Animal Protein
Amyris, Inc. (NASDAQ:AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM operating platform, today
Britain Approves Moderna’s COVID-19 Vaccine For Kids Aged 6-11 Years
Britain’s medicines regulator approved the use of Moderna Inc’s (NASDAQ:MRNA) COVID-19 vaccine in children between six and 11 years. The Medicines and…
Morgan Stanley Maintains Equal-Weight on Healthpeak Properties, Raises Price Target to $37
Morgan Stanley analyst Richard Hill maintains Healthpeak Properties (NYSE:PEAK) with a Equal-Weight and raises the price target from $32 to $37.